• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of August 8, 2012

  • Print
  • Share
  • E-mail

Product Detail

Product Description Red Blood Cells Leukocytes Reduced
Recall Number B-1533-12
Classification Class II
Code Info W115912050151; W115911055120; W115911087792; W115911086284; W115911028245; W115911026948; W115911028133; W115911026079; W115911242742; W115911276347; W115911056484; W115911055417; W115911283967; W115911087172; W115911265921; W115911265619; W115911086370; W115911265213; W115911265258; W115911026455; W115911025188; W115911046827; W115911273078; W115911046723; W115911242945; W115911242946; W115911276348; W115911055415; W115911084863; W115911087547; W115912250344; W115911276278; W115912040618; W115911087738; W115912080071; W115911201854; W115911027557;
Product Distributed Qty 37
Reason For Recall Blood products, collected from a donor who traveled to a malaria endemic area, were distributed.

Event Detail

Event Id 61784
Product Type Biologics
Status Terminated
Recalling Firm Central California Blood Center
City Fresno
State CA
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2012-03-28
Initial Firm Notification of Consignee or Public E-Mail
Distribution Pattern Ohio; Maryland; California; New York